Whilst dietary deficiency is less common in the UK than in developing countries, it remains an important consideration in certain populations
Its about finding the minimum effective dose, not the maximum tolerable one
Here are the questions you need to answer
References National Institute for Health and Care Excellence
Third-party testing: Do they test for potency and sterility
Sulofenur [( N -(5-indanesulfonyl)- N -(4-chlorophenyl)urea, LY18664], the prototypic member of this class ( Figure 2C ), was evaluated in clinical trials on a variety of patients with kidney (Mahjoubi et al., 1993), ovary (OBrien et al., 1992), breast (Talbot et al., 1993), lung (Munshi et al., 1993), and stomach (Kamthan et al., 1992) cancers